Thank you for joining us. Today is May 31st, 2023. It's 12:00 P.M. Eastern Time and 9:00 A.M. Pacific Time. This is Reliq Health Technologies corporate update. I am Lisa Crossley, the CEO, and this will be an overview of our Q3 financials as well as a look forward. Please review the forward-looking statements disclaimer at your leisure, and interpret any remarks from today's presentation in that context. For today's webinar, I'm going to provide a brief overview of the Q3 fiscal year 2023 financials, so for the period ending March 31st, 2023. I'll provide an outlook for the remainder of the calendar year and then go through some very quick shareholder FAQs and the upcoming webinar dates subsequent to this one. Overall, what I expect to cover during this webinar is fairly brief. As you all know, we made some substantial changes to our business model beginning in January of this year. The quarter that we're reporting on here, which was two months ago, it ended, was really the quarter where we first started to implement those changes. Not a lot of the progress that we made is reflected in these financials, but will certainly be reflected in future financials. Let's jump into the Q3 results. The highlights for the quarter ending March 31st were an increase in revenue of over 88% to roughly $4.7 million. We also increased our revenue from the higher margin software and services sales by 69% to about $1.8 million. You will definitely see much more significant increases in software sales going forward. This quarter, we were a little bit hampered by the hardware orders that we'll talk about a little more, in a little more detail in subsequent slides, but because we had some large hardware orders that were deferred, the software revenues associated with those hardware orders were also deferred, as I've disclosed before. You will certainly begin to see much more significant growth on the software side, over the rest of this year and beyond. This was our first profitable quarter, and I think that definitely does reflect some of the changes that we've made to the business model. We had a net gain of $731,000, and our adjusted EBITDA has improved by over 2,000% relative to the same period last year. That's primarily just adjusting for non-cash expenses. They're very small, non-recurring expenses in that adjustment. During the last three months, we certainly made some significant progress on the business development front. We continued to expand in the skilled nursing facility space, adding over 120 new skilled nursing facilities over the last five months, actually, the quarter ending March 31st and subsequent. We also signed new contracts with some very significant large healthcare organizations, one of which was a large U.S. healthcare system that operates over 1,200 care centers across seven U.S. states, including the skilled nursing facilities, hospitals, home health agencies, hospice agencies, and primary care clinics. They have over 10 million patient encounters a year across their network. They, and the other large clients we've signed, do very extensive due diligence before they select a company to be their partner for remote patient monitoring, behavioral health integration, chronic care management, transitional care management, et cetera. It is really a testament to our unique value proposition in this space and to the future potential for this company. Excuse me. We also signed a new contract with a large U.S. health plan that operates Accountable Care Organizations in five U.S. states, with over 3,000 doctors and more than 1 million patients. This client in particular, it's our first health plan, but they are also a subsidiary of one of the nation's largest providers of hospital and healthcare services, who is also a Fortune 500 company. We really are getting into some of the blue-chip clients. I think, you know, it's important to remember that with these very large clients, they like to start out with a phased deployment. I've talked about that a lot over the years, and that's very typical in healthcare for healthcare software deployments, that they will start small, roll out to a specific geography or a specific type of facility, or even to a subset of patients from a given facility, and then expand from there. The initial deployments that we've announced with these large clients are relatively small compared to their patient population overall, but they are the first step in phased deployments. As we have more details and more established implementation plans with these larger clients, we'll be able to provide updates. Certainly, our expectation is that we will see significant growth from these new clients, beyond the initial phase. What we've announced to date is really, effectively the tip of the iceberg. The outlook for the remainder of the year and beyond as you all know, historically, the company's been very focused on new business development and capturing market share, that real estate grab that we talked about. As of the beginning of this year, we really expanded our focus to include a real significant efforts towards improving profitability and cash flows. I think you can see the improvement in profitability very clearly in these financials. The cash flows are going to come as collections pick up, and certainly so are the top-line revenues associated with improved adherence. I'll discuss that a little bit further in subsequent slides. As we've disclosed on previous webinars, the company has $15 million in contracted hardware sales, so we've received orders from clients for $15 million worth of hardware. We've started shipping the hardware, which is the point at which we can recognize revenue, but the majority of the orders are expected to be fulfilled by the end of the fiscal year. We started shipping in the quarter ending March 31st, but the bulk of that revenue will land in the current quarter, which ends June 30th. As you know, hardware is sold on 12-24 month payment plans. We've had some of the initial scheduled payments for the hardware that's already been shipped, come in, but we'll see that those payments ramp up significantly in the second half of the calendar year, once we've been able to ship all of that hardware in the current fiscal year. All of those hardware orders will translate to subsequent software revenue. It is a very meaningful order for the company, not just in terms of the hardware revenue, but in terms of the software and services revenue that will follow behind. Since January 1st, the company's been very focused on improving patient adherence by taking over adherence management from clients. I want to address this particular topic in some detail because I think there's an expectation in some quarters that when we say we're taking over managing adherence, that we flip a switch and that happens overnight, and that's certainly not the case. We made some good progress in Q1, getting a percentage of our patient population or our client population moved over to Reliq, handling the adherence management. But even once we get those patients, it does take sort of a month or two, at most three, for us to get those patients onboarded and, well, they're already onboarded, but comfortable with us managing the adherence and actually start to improve. We do see dramatic improvements in adherence in these patients once we've taken over managing that piece from their clinicians. It's not an instantaneous or overnight change, so you aren't going to see much of an impact on top-line revenues in the quarter ending March 31st, that are a result of improving the adherence. You will start to see the impact of the improvements in adherence management in the quarter ending June 30th, but where you'll really start to see the significant increases and the impacts on revenues will be in the second half of the year. Certainly it'll be a much more significant impact. It'll have a much more significant impact on the quarter that we'll report or that is ending June 30th, but it will continue to improve beyond that. The average adherence is expected to exceed 70% by the end of the calendar year. Adherence levels interestingly, appear to be consistently higher with the patients from the larger healthcare organizations than from the individual physician practices. Historically, we have had a customer base that was primarily individual physician practices and home health agencies. Beginning late last year, 2022, we started to acquire more and more of these larger healthcare clients, skilled nursing facilities, Accountable Care Organizations, and other health plans, et cetera. We find with those groups that, A, they have resources, for example, with the skilled nursing facility, where they will have these patients trained in using the system before they even are discharged, which really helps with adherence levels. But also their performance metrics are so well aligned with what we do as a business, that we see more, I'll call it motivation, from the larger clients to really work with patients and to commit whatever is necessary in order to ensure that their patient population is adherent. It's a little bit different from the way that the individual physician practices in the home health agencies approach RPM and CCM. That's to our benefit, because going forward, we expect that the majority of our clients will be these larger healthcare organizations. Certainly, the majority of patients that we have in our on our platform will come from the large clients. That's going to make it easier for us to improve adherence levels even beyond the 70% level as we move into 2024 and beyond. Collections, again, you know, I want to emphasize it's something that we put a lot of effort into and that is improving dramatically, but we really didn't start to see the impact of our efforts, the account managers' efforts, until March. There's not a lot of collections that are reflected in the financials ending March 31st, but you will certainly see a significant impact of our efforts in accelerating collections in the quarter ending June 30th. By the time we get to the end of June, we should have all of our clients caught up on all of their receivable, all of our receivables, their payables. Going forward, we will be able to keep all of our clients on a regular payment schedule so that they we don't have that same issue where we have these aging receivables. I'll remind everyone that there will always be a portion of our receivables that will relate to hardware that's on 12-24-month payment plans. There will always be a fairly large receivable number on our books, but there will be essentially no stale receivables, or these, you know, very aging receivables that we see around the software and services revenue, where clients have needed a little bit of nagging in order to pay. Because we are going to be receiving, or collecting or have started to collect, all of the receivables that are expected by the end of June, we will be in a much better cash position going forward for the second half of the year and beyond. Just some very brief shareholder FAQs. We have been getting a lot of questions about Accountable Care Organizations and with ACOs. These are groups of physicians and sometimes other healthcare providers who aren't necessarily located in the same facility or even in the same city, but they've effectively banded together on a back-office basis to form Centers for Medicare and Medicaid Services approved entity that is compensated based on value. For CMS, value means patients have better health outcomes and therefore lower healthcare costs. CMS financially incense the ACOs to reduce healthcare costs by using a shared savings model. The ACO members will receive a portion of the cost savings that they achieve for patients. The best way to reduce costs for these patients is by reducing hospitalizations. That's really where the bulk of the costs for the chronic disease patients come from, is these exacerbations that translate to a hospital stay. Our platform, the iUGO Care platform, has been proven to reduce hospitalizations and the associated healthcare costs by over 80%. Our solutions are perfectly aligned with the ACOs performance metrics, as they are also very well aligned with skilled nursing facilities and many of these other large healthcare organizations. We expect that we will start to see increasing traction with the ACOs now that we've landed our first really very large multi-state ACO. This is not phrased, this next point, as a question, but it is something that we are asked consistently, so I just want to repeat that we don't expect to need to raise capital or take on debt to fund operations. We expect to initiate a share buyback program later this year. As soon as we have sufficient free cash flow, we will pull the trigger on that, because obviously we want to initiate the share buyback at a compelling price point for the company. Upcoming webinars. As I've said repeatedly, I think there will be a lot more meaningful data that will demonstrate the improvements in adherence and collections, but when we close out the quarter that ends June 30th. Obviously, that's our fiscal year-end, so we will be issuing the annual audited financials or filing them in October of this year. We will hold an interim webinar in the middle of July. The exact date will be determined in June, and we'll announce that date in probably early July. At that point, I think we'll be able to get a lot more granular with our reporting and sharing, you know, the various metrics with all of you so that it's easier to build your models. I know it's been a bit frustrating, but the company has been very focused on making the necessary changes so that the business model going forward really supports, not just the really strong revenue growth, but profitability and strong cash flows. We've needed to do that work, and I think we'll be at a point where we have all of the clients moved over to us managing adherence, and that will allow us, I think, going forward, to provide more details in our reporting and to probably help some of you construct the models that you I know, like to work on. As I say, we are filing the annual audited financials in October. We'll do this interim progress update webinar in July, but we'll also do a second update webinar in early September. Again, exact date is to be determined, but that will provide another touch point between now and when we do file the annual audited financials, so that we can share the meaningful progress that we'll be able to show from here going forward, and without having to wait months and months and months to file that, those annual audited statements. Thank you very much for joining us. We greatly appreciate your time. The webinar will be available on our website later today, as soon as we are able to get it up, some, which is sometimes in our control and sometimes not, depending on the webinar provider, but we will get that up as soon as we can. Again, thank you very much for joining us.